Matters

Stibbe advises Walter de Gruyter GmbH on its intended recommended all-cash public offer for all securities in Koninklijke Brill N.V.

Breakthrough Properties, the global life sciences real estate developer, is expanding its European footprint and will develop Neogene Therapeutics’ new European headquarters within the campus of the Amsterdam University Medical Centre (Amsterdam UMC).

Stibbe has advised a group of senior lenders to the Keter Group on the successful completion of a transaction that includes maturity extensions of the Group’s senior and holdco PIK facilities.

Stibbe assisted AustralianSuper with its investment of €1.5 billion to acquire a significant minority stake in Vantage Data Centers Europe, Middle East and Africa (Vantage EMEA).

Stibbe is advising Barça Produccions and Barcelona Football Club alongside Spanish law firm Perez Llorca in relation to a business combination agreement with Mountain & Co. I Acquisition Corp.

We are delighted to have contributed to the establishment of Stichting Emergent Justice Collective. The object of this foundation is to challenge the existing dominant power within the international legal system.

Stibbe advised PeakSpan Capital with over EUR 1.5 billion under management alongside co-investors Fortino Capital, Newion Partners, Expon Capital and LBAN with the investment into a JV Luxembourg company named Salonkee S.A..

Stibbe is acting as lead counsel to Benelux investment firm Torqx Capital Partners on its intended recommended all-cash public offer for 100% of the shares in Beter Bed Holding N.V.

Stibbe advised Goed, the network of pharmacies, home care shops and audiology shops of health insurance fund​ CM, on the sale of its hearing centres chain to Audika Belgium.

Stibbe advised Rhône Capital on a public cash offer for up to 29.9% of the share capital in RHI Magnesita N.V. The offer document was published on 19 June 2023 following an announcement of the intended transaction on 30 May 2023.